Friebel Rocco, Dharmarajan Kumar, Krumholz Harlan M, Steventon Adam
*School of Public Health, Imperial College London, South Kensington Campus †Data Analytics, The Health Foundation, London, UK ‡Center for Outcomes Research and Evaluation, Yale-New Haven Hospital §Section of Cardiovascular Medicine and the Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale School of Medicine ∥Department of Health Policy and Management, Yale School of Public Health, New Haven, CT.
Med Care. 2017 Sep;55(9):834-840. doi: 10.1097/MLR.0000000000000779.
Although many hospital readmission reduction initiatives have been introduced globally, health care systems ultimately aim to improve patients' health and well-being. We examined whether the hospitals that report greater success in reducing readmissions also see greater improvements in patient-reported outcomes.
We examined hospital groups (Trusts) that provided hip replacement or knee replacement surgery in England between April 2010 and February 2013. For each Trust, we calculated risk-adjusted 30-day readmission rates from administrative datasets. We also obtained changes in patient-reported health between presurgical assessment and 6-month follow-up, using general health EuroQuol five dimensions questionaire (EQ-5D) and EuroQuol visual analogue scales (EQ-VAS) and procedure-specific (Oxford Hip and Knee Scores) measures. Panel models were used to assess whether changes over time in risk-adjusted readmission rates were associated with changes over time in risk-adjusted health gains.
Each percentage point reduction in the risk-adjusted readmission rate for hip replacement was associated with an additional health gain of 0.004 for EQ-5D [95% confidence interval (CI), 0.002-0.006], 0.39 for EQ-VAS (95% CI, 0.26-0.52), and 0.32 for Oxford Hip Score (95% CI, 0.15-0.27). Corresponding figures for knee replacement were 0.003 for EQ-5D (95% CI, 0.001-0.004), 0.21 for EQ-VAS (95% CI, 0.12-0.30), and 0.14 in the Oxford Knee Score (95% CI, 0.09-0.20).
Reductions in readmission rates were associated with modest improvements in patients' sense of their health and well-being at the hospital group level. In particular, fears that efforts to reduce readmission rates have had unintended consequences for patients appear to be unfounded.
尽管全球已推出多项降低医院再入院率的举措,但医疗保健系统的最终目标是改善患者的健康状况和福祉。我们研究了那些在降低再入院率方面取得更大成功的医院,其患者报告的结果是否也有更大改善。
我们研究了2010年4月至2013年2月期间在英格兰提供髋关节置换或膝关节置换手术的医院集团(信托机构)。对于每个信托机构,我们从行政数据集中计算风险调整后的30天再入院率。我们还使用欧洲五维健康量表(EQ-5D)、欧洲视觉模拟量表(EQ-VAS)以及特定手术量表(牛津髋关节和膝关节评分),获取了术前评估至6个月随访期间患者报告的健康变化情况。采用面板模型评估风险调整后的再入院率随时间的变化是否与风险调整后的健康收益随时间的变化相关。
髋关节置换手术的风险调整再入院率每降低一个百分点,EQ-5D的额外健康收益为0.004[95%置信区间(CI),0.002 - 0.006],EQ-VAS为0.39(95%CI,0.26 - 0.52),牛津髋关节评分为0.32(95%CI,0.15 - 0.27)。膝关节置换手术的相应数据为,EQ-5D为0.003(95%CI,0.001 - 0.004),EQ-VAS为0.21(95%CI,0.12 - 0.30),牛津膝关节评分为0.14(95%CI,0.09 - 0.20)。
在医院集团层面,再入院率的降低与患者对自身健康和福祉感受的适度改善相关。特别是,担心降低再入院率的努力会对患者产生意外后果似乎是没有根据的。